Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors

被引：1
|
作者：
Einama, Takahiro [1 ,4 ]
Kawamata, Futoshi [1 ]
Kamachi, Hirofumi [1 ]
Nishihara, Hiroshi [2 ]
Homma, Shigenori [1 ]
Matsuzawa, Fumihiko [1 ]
Mizukami, Tatsuzo [1 ]
Konishi, Yuji [1 ]
Kamiyama, Toshiya [1 ]
Yamamoto, Junji [4 ]
Taketomi, Akinobu [1 ]
Todo, Satoru [3 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Sapporo, Hokkaido 0608638, Japan
[2] Natl Hosp Org, Hokkaido Canc Ctr, Dept Pathol, Sapporo, Hokkaido 0030804, Japan
[3] St Marys Hosp, Res Inst, Kurume, Fukuoka 8308558, Japan
[4] Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
来源：
EBIOMEDICINE | 2017年 / 24卷
关键词：
GASTRIC-CANCER; ERC/MESOTHELIN; ADENOCARCINOMA;
D O I：
10.1016/j.ebiom.2017.09.033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [21] Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies
    Briolay, Tina
    Fresquet, Judith
    Meyer, Damien
    Kerfelec, Brigitte
    Chames, Patrick
    Ishow, Elena
    Blanquart, Christophe
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 633 - 650
  • [22] Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
    Hassan, Raffit
    Cohen, Steven J.
    Phillips, Martin
    Pastan, Ira
    Sharon, Elad
    Kelly, Ronan J.
    Schweizer, Charles
    Weil, Susan
    Laheru, Daniel
    CLINICAL CANCER RESEARCH, 2010, 16 (24) : 6132 - 6138
  • [23] Initial clinical experience of 111In radiolabelled amatuximab in patients with mesothelin-expressing cancers
    Lindenberg, Liza
    Adler, Stephen
    Thomas, Anish
    Maltzman, Julia
    Wallin, Bruce
    Mena, Esther
    Kurdziel, Karen
    Paik, Chang
    Choyke, Peter
    Hassan, Raffit
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [24] Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers
    O'Hara, Mark H.
    Stashwick, Caitlin
    Plesa, Gabriela
    Tanyi, Janos L.
    IMMUNOTHERAPY, 2017, 9 (09) : 767 - 780
  • [25] Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts
    Hassan, Raffit
    Broaddus, V. Courtney
    Wilson, Shannon
    Liewehr, David J.
    Zhang, Jingli
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7166 - 7171
  • [26] Phase I study of autologous T cells bearing fully-humanized chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
    Tanyi, Janos
    Haas, Andrew
    Aggarwal, Charu
    O'Hara, Mark
    Lacey, Simon
    Golden, Ryan
    Hwang, Wei-Ting
    Young, Regina
    Sheppard, Neil
    Albelda, Steven
    June, Carl
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S164 - S165
  • [27] Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
    Hong, D. S.
    SciMentum, S. L.
    Tanyi, J.
    MacMullen, L.
    Jalbert, L.
    Muzithras, V. P.
    Zikaras, K.
    Cao, L.
    O'Cearbhaill, R. E.
    Quintas-Cardama, A.
    Hassan, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S830 - S830
  • [28] New cancer prevention model using imaging for early detection of mesothelin-expressing cancers
    Sharma, Khushboo
    Yin, Catherine
    Kamat, Kalika
    Repellin, Claire
    Sambucetti, Lidia C.
    Scholler, Nathalie
    CANCER RESEARCH, 2017, 77
  • [29] Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells
    Wang, Dong-hui
    Wu, Xiao-hua
    Qian, Su-min
    Yao, Hai-Rong
    MEDICAL ONCOLOGY, 2015, 32 (04) : 1 - 9
  • [30] Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
    Hagerty, Brendan L.
    Pegna, Guillaume J.
    Xu, Jian
    Tai, Chin-Hsien
    Alewine, Christine
    BIOMOLECULES, 2020, 10 (07) : 1 - 18
12345